OPPOSITION PENDING
on 07 Nov 2024
Last Applicant/ Owned by
2900 37th Street NW
Rochester
MN
55901
Serial Number
98122765 filed on 08th Aug 2023
Registration Number
N/A
Correspondent Address
MICHELLE L. ZIMMERMANN
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
VYRIAD
Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; research anddevelopment of bio-pharmaceuticals for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; medicaland scientific research in the fields of genetics and oncology; research and development of technology in the fields of stem cellsand stem cell therapy Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research and development in the fields of cancer treatment and oncolytic virotherapy; research anddevelopment of bio-pharmaceuticals for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; medicaland scientific research in the fields of genetics and oncology; research and development of technology in the fields of stem cellsand stem cell therapy for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; development ofgenetic therapies and chimeric antigen receptor cell (CAR-T) cell therapies for the treatment of cancer, cardiovascular diseases,and heritable genetic diseases; scientific research and development of cell therapies, namely, chimeric antigen receptor T-cells(CAR-T) to cure solid tumor cancers and other cancers; medical and scientific research services in the fields of genetics, celltherapy, oncology, immuno-oncology; all of the foregoing to exclude infectious diseases
First Use Date in General
26th Oct 2016
First Use Date in Commerce
26th Oct 2016
Class [005]
Pharmaceutical Products
Pharmaceuticals, namely, bio-pharmaceuticals for the treatment of cancer; stem cells for medical use for the treatment of cancer,cardiovascular diseases, and heritable genetic diseases; medicinal preparations for use in oncology; pharmaceutical preparationsfor the treatment of immune system related diseases and disorders, namely, cancer and cardiovascular diseases and heritablegenetic diseases; pharmaceutical preparations for treatment of genetic and heritable genetic diseases; cellular pharmaceuticalpreparations for use in oncology and cardio-vascular diseases; living tissue in the nature of chimeric antigen receptor (CAR-T)cells for medical use for the treatment of cancer, cardiovascular diseases, and heritable genetic diseases; pharmaceuticalpreparations for use in oncology; all of the foregoing to exclude infectious diseases
First Use Date in General
26th Oct 2016
First Use Date in Commerce
26th Oct 2016
Mark Details
Serial Number
No 98122765
Mark Type
No Service Mark
Attorney Docket Number
No 291900
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 07th Nov 2024 | OPPOSITION INSTITUTED NO. 999999 |
| 07th Nov 2024 | OPPOSITION PAPERS RECEIVED AT TTAB |
| 04th Nov 2024 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
| 21st Oct 2024 | ASSIGNED TO PETITION STAFF |
| 08th Oct 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 08th Oct 2024 | PUBLISHED FOR OPPOSITION |
| 03rd Oct 2024 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 18th Sep 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 05th Sep 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 14th Jun 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |